Cipla launches initiative to improve access to nebulisers for acute asthma management in primary health care centres of rural India Kumar Jeetendra | December 10, 2021 Mumbai, 10th December 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections of the country. With Cipla’s unmatched presence across the care continuum and a wide range of drug-device combinations and treatments, the …
Alembic Pharmaceuticals receives USFDA Tentative Approval for Selexipag Tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg. Kumar Jeetendra | December 8, 2021 8th December, 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that the Company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Selexipag Tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg. The tentatively approved ANDA is therapeutically equivalent …
Venair presented at interphex its new updated tubing range and products Kumar Jeetendra | December 7, 2021 Barcelona, Spain – 7 December 2021 – Life Science Newswire – During October 19-20-21 the Interphex international trade fair was held in New York, an event which stands out for the massive participation of the best companies in the pharmaceutical and biotechnology sector. They take advantage of this great occasion to present their new products …
Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients Kumar Jeetendra | November 30, 2021 Bangalore, Nov. 30, 2021 – Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company advancing innovative medicines to prevent and treat life-threatening diseases, has selected AWS as its preferred cloud provider. Innovating on AWS and with the help of AWS experts and …
Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Mupirocin Cream USP, 2%. Kumar Jeetendra | November 20, 2021 17th November 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mupirocin Cream USP, 2%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), …
Cipla launches Spirofy®: Strengthens its lung leadership position by facilitating early diagnosis for COPD1 Kumar Jeetendra | November 17, 2021 Mumbai, India; November 17, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced the launch of Spirofy®, India’s first pneumotach based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its …
Cipla ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Emerging Markets Index Kumar Jeetendra | November 15, 2021 Mumbai, India; November 15, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced today that it has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging Markets for 2021. The DJSI family of indices is operated by one of the world’s leading index providers S&P …
Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study Kumar Jeetendra | November 12, 2021 Hyderabad, Nov 12 (PTI) Bharat Biotech’s vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group, Phase III data published in The Lancet said on Friday.The efficacy data which was peer reviewed …
BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry Kumar Jeetendra | October 26, 2021 26 October 2021 – Life Science Newswire – BioPharma Dynamics, a leading life sciences solution provider, proudly announce the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester. This expansion sees the company treble in size, with its new premises adding the capacity for product assembly and …
Alembic Pharma gets EIR from USFDA for Karakhadi office Kumar Jeetendra | October 13, 2021 Drug firm Alembic Pharmaceuticals on Monday said it has received establishment inspection report (EIR) from the US health regulator for its new injectable facility at Karakhadi in Gujarat. The company has, ”received EIR from US Food and Drug Administration (USFDA) for the inspection carried out by them at our new injectable facility at Karakhadi during …
Lincoln Pharmaceuticals Ltd receives approval from Australian Regulator, TGA Kumar Jeetendra | October 9, 2021 Ahmedabad, October 8, 2021: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has received approval from Australia’s medicines and medical devices regulator – Therapeutic Goods Administration (TGA). Company’s manufacturing facility in Khatraj, Gujarat received the GMP clearance from TGA for all three departments Tablet, Capsule and Cream & Ointment, which will cover a wide …
Lupin gets speculative gesture from USFDA to market generic Brexpiprazole tablets Kumar Jeetendra | October 8, 2021 Drug firm Lupin on Wednesday said it has received tentative nod from the US health regulator to market generic Brexpiprazole tablets, which are used with anti-depressant medicines for the treatment of major depressive disorder, in the American market. The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market …
